INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

9475	Companies
185452	Keywords
117793	Articles
99303	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 05/22/2025 at 14:05, 6 months 13 days ago

Inventiva Unveils Details of Share Repurchase Program

Share Repurchase Liquidity Agreement Capital Reduction Market Stability Employee Stock Options
PRESS RELEASE

published on 05/22/2025 at 14:00, 6 months 13 days ago

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
Inventiva implements share repurchase program with Kepler Chevreux under liquidity agreement approved by Ordinary General Meeting. Program details and objectives announced for 18-month period

Liquidity Agreement Ordinary General Meeting Share Repurchase Program Inventiva Kepler Chevreux
BRIEF

published on 05/15/2025 at 14:31, 6 months 20 days ago

Crossing thresholds at INVENTIVA

Voting Rights Capital Capital Increase Crossing Thresholds Inventiva
BRIEF

published on 05/15/2025 at 14:30, 6 months 20 days ago

Threshold crossing by Invus at INVENTIVA

Capital Increase Threshold Crossing Shares And Voting Rights Inventiva Invus Public Equities
BRIEF

published on 05/13/2025 at 11:29, 6 months 23 days ago

Crossing of thresholds by Samsara BioCapital in INVENTIVA

Warrants Capital Increase Crossing Thresholds Inventiva Samsara BioCapital
PRESS RELEASE

published on 05/05/2025 at 08:30, 7 months ago

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
BRIEF

published on 04/24/2025 at 22:06, 7 months 10 days ago

Inventiva Unveils New Biomarker Analysis for MASH Treatment

Lanifibranor MASH Treatment Biomarker Signatures Histological Response Predictive Accuracy
PRESS RELEASE

published on 04/24/2025 at 22:01, 7 months 10 days ago

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
Inventiva announces publication in Clinical Gastroenterology and Hepatology of non-invasive biomarker signatures predictive of histological response in MASH patients treated with lanifibranor

Inventiva Lanifibranor Biomarker Signatures Histological Response Clinical Gastroenterology
BRIEF

published on 04/15/2025 at 22:05, 7 months 19 days ago

Inventiva Files 2024 Financial Documents with Regulatory Agencies

Biopharmaceutical Regulatory Filing Inventiva MASH 2024 Financials
PRESS RELEASE

published on 04/15/2025 at 22:00, 7 months 19 days ago

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
Inventiva files its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F with the AMF and SEC. Documents accessible on Inventiva's website and regulatory authorities' sites

2024 Form 20-F Registration Document Clinical-Stage Biopharmaceutical Inventiva

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 40 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 45 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 15 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 10 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 15 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:00, 15 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 15 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 10 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 15 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 15 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 30 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 15 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 30 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE